Brachytherapy: An overview for clinicians

C Chargari, E Deutsch, P Blanchard… - CA: a cancer journal …, 2019‏ - Wiley Online Library
Brachytherapy is a specific form of radiotherapy consisting of the precise placement of
radioactive sources directly into or next to the tumor. This technique is indicated for patients …

Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies

WC Jackson, J Silva, HE Hartman, RT Dess… - International Journal of …, 2019‏ - Elsevier
Purpose Utilization of stereotactic body radiation therapy (SBRT) for treatment of localized
prostate cancer is increasing. Guidelines and payers variably support the use of prostate …

Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management

JA Eastham, GB Auffenberg, DA Barocas… - The Journal of …, 2022‏ - auajournals.org
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Androgen suppression combined with elective nodal and dose escalated radiation therapy (the ASCENDE-RT Trial): an analysis of survival endpoints for a …

WJ Morris, S Tyldesley, S Rodda, R Halperin… - International Journal of …, 2017‏ - Elsevier
Purpose To report the primary endpoint of biochemical progression-free survival (b-PFS)
and secondary survival endpoints from ASCENDE-RT, a randomized trial comparing 2 …

High-risk prostate cancer—classification and therapy

AJ Chang, KA Autio, M Roach III, HI Scher - Nature reviews Clinical …, 2014‏ - nature.com
Approximately 15% of patients with prostate cancer are diagnosed with high-risk disease.
However, the current definitions of high-risk prostate cancer include a heterogeneous group …

ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam …

S Rodda, S Tyldesley, WJ Morris, M Keyes… - International Journal of …, 2017‏ - Elsevier
Purpose To report the genitourinary (GU) and gastrointestinal (GI) morbidity and erectile
dysfunction in a randomized trial comparing 2 methods of dose escalation for high-and …

GEC-ESTRO ACROP prostate brachytherapy guidelines

A Henry, BR Pieters, FA Siebert, P Hoskin - Radiotherapy and Oncology, 2022‏ - Elsevier
This is an evidence-based guideline for prostate brachytherapy. Throughout levels of
evidence quoted are those from the Oxford Centre for Evidence based Medicine …

Past, present, and future of radiotherapy for the benefit of patients

J Thariat, JM Hannoun-Levi, A Sun Myint… - Nature reviews Clinical …, 2013‏ - nature.com
Radiotherapy has been driven by constant technological advances since the discovery of X-
rays in 1895. Radiotherapy aims to sculpt the optimal isodose on the tumour volume while …

Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β= 1.4 (0.9–2.2) …

R Miralbell, SA Roberts, E Zubizarreta… - International Journal of …, 2012‏ - Elsevier
PURPOSE: There are reports of a high sensitivity of prostate cancer to radiotherapy dose
fractionation, and this has prompted several trials of hypofractionation schedules. It remains …

Prostate cancer, version 2.2014

JL Mohler, PW Kantoff, AJ Armstrong… - Journal of the National …, 2014‏ - jnccn.org
Prostate cancer has surpassed lung cancer as the most common cancer in men in the
United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary …